A carregar...
Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors
SIMPLE SUMMARY: Ovarian cancer treatment is the deadliest of gynecological cancers but the introduction of target therapies in its therapeutic algorithm has significantly improved outcomes. The aim of this article was to provide a review of completed and ongoing clinical trials involving the use of...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7999042/ https://ncbi.nlm.nih.gov/pubmed/33803954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061298 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|